These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 25438725

  • 1. Reviewing a clinical decision aid for the selection of anticoagulation treatment in patients with nonvalvular atrial fibrillation: applications in a US managed care health plan database.
    Deitelzweig SB, Jing Y, Swindle JP, Makenbaeva D.
    Clin Ther; 2014 Nov 01; 36(11):1566-1573.e3. PubMed ID: 25438725
    [Abstract] [Full Text] [Related]

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 3. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M, Lip GY, Nieuwlaat R, Pisters R, Crijns HJ, Iorio A.
    Am J Med; 2014 Oct 10; 127(10):979-986.e2. PubMed ID: 24838192
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.
    Yao X, Gersh BJ, Sangaralingham LR, Kent DM, Shah ND, Abraham NS, Noseworthy PA.
    Am J Cardiol; 2017 Nov 01; 120(9):1549-1556. PubMed ID: 28844514
    [Abstract] [Full Text] [Related]

  • 5. Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
    Lip GY, Lanitis T, Mardekian J, Kongnakorn T, Phatak H, Dorian P.
    Stroke; 2015 Oct 01; 46(10):2830-7. PubMed ID: 26316345
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study).
    Jaakkola S, Kiviniemi TO, Nuotio I, Hartikainen J, Mustonen P, Palomäki A, Jaakkola J, Ylitalo A, Hartikainen P, Airaksinen KEJ.
    Am J Cardiol; 2018 May 15; 121(10):1182-1186. PubMed ID: 29526276
    [Abstract] [Full Text] [Related]

  • 7. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y, Wang H, Tian Y, Wang Y, Lip GYH.
    Chest; 2015 Jul 15; 148(1):62-72. PubMed ID: 25501045
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.
    Kjerpeseth LJ, Ellekjær H, Selmer R, Ariansen I, Furu K, Skovlund E.
    Eur J Clin Pharmacol; 2018 Dec 15; 74(12):1653-1662. PubMed ID: 30116828
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs.
    Deitelzweig S, Sah J, Kang A, Russ C, Preib M, Dhamane AD, Ratiu A, Cato M, Alfred T, Levi E, Di Fusco M.
    Am J Cardiol; 2022 Jan 15; 163():43-49. PubMed ID: 34930532
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.
    Kim TH, Yang PS, Kim D, Yu HT, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, Lip GYH.
    Stroke; 2017 Nov 15; 48(11):2984-2990. PubMed ID: 28939672
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG, Xiong QM, Hong K.
    Tex Heart Inst J; 2015 Feb 15; 42(1):6-15. PubMed ID: 25873792
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
    Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L.
    Chest; 2018 Nov 15; 154(5):1121-1201. PubMed ID: 30144419
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.